Page 343 - Invited Paper Session (IPS) - Volume 2
P. 343

IPS273 Tomoki Tokuda et al.

            labelled ‘Treatment Effect’ in Fig.3. A higher value in these features implies that
            a patient is not remitted. Therefore, we can characterize D1, D2, and D3 as
            resistant, responsive, and responsive clusters for SSRI treatment. Furthermore,
            features related to CATS are included in the same feature cluster F1. These
            results suggest that the subject clusters D1, D2 and D3 for depressive subjects
            may be related to after-treatment status of depression, which might be further
            related to stress experiences during childhood. Lastly, feature clusters F2 and
            F4  are  related  to  specific  functional  connectivity  in  fMRI  image  data  (i.e.,
            angular-gyrus related FC), which suggests a possible association between the
            subject clusters and neural substrates.
               This result of cluster analysis raises the possibility of prediction of treatment
            outcome prior to SSRI treatment. In this regard, we explore several important
            implications drawn from the result. First, subject clusters can be represented
            by a small number of relevant features. Since in our clustering method each
            feature cluster consists of similar (i.e., highly correlated) features, a feature
            cluster can be represented by a reduced number of these features. It turns out
            that  the  subject  clusters  D1,  D2  and  D3  are  represented  by  CATS  scores
            (associated to feature cluster F1), and the first principal scores of angulargyrus
            related FC (associated to F2 and F4; we simply refer to it ‘AG related FC score’).
            These features can indeed explain the resultant subject cluster membership
            properly  (Fig.4A).  In  the  scatter  plot  of  Fig.4A,  AG-related  FC  scores
            discriminate between subjects in D3 and other subjects. On the other hand,
            CATS scores do not discriminate a single class by itself, but they discriminate
            between  subjects  in  D1  and  D2,  once  subjects  in  D3  are  sorted  out.  This
            observation motivated us to consider a classifier that consists of the following
            steps. First, we classify subjects into either D3 or non-D3 based on AGrelated
            FC scores. A subject with low scores in AG-related FC is classified into D3,
            otherwise into non-D3. Subsequently, the non-D3 subjects are classified into
            either D1 or D2 based on CATS scores: A subject with low scores in CATS is
            classified  into  D2,  otherwise  into  D1.  This  procedure  of  classification  is
            summarized in Fig.4B. Since these subject clusters correspond to degrees of
            remission  of  SSRI  treatment  as  well,  this  classifier  leads  to  predictions  of
            whether SSRI treatment may be effective, prior to the onset of treatment. We
            can  interpret this classification as  follows. For  subjects in D2 and D3, SSRI
            treatment may be appropriate (low after-six-week BDI scores), while it may not
            for those in D1.











                                                               330 | I S I   W S C   2 0 1 9
   338   339   340   341   342   343   344   345   346   347   348